PPARG and diabetic neuropathy: Inhibitors of PPARG ameliorated phenotypes in mouse models of chemotherapy-induced and diabetic neuropathy due to its neuroprotective properties,15,16 but a direct link connecting PPARG to peripheral neuropathy is not evident.